The credit rating of two companies listed in the capital market has been completed. The two companies are – Ibn Sina Pharmaceutical Industries plc and Navana Pharmaceuticals plc.
According to sources, Ibn Sina Pharma’s credit rating has been assessed by Alpha Credit Rating Limited. The company is rated ‘AA+’ for long term and ‘ST-1’ for short term. This rating has been determined based on the audited financial report for the financial year ended on June 30, 2024 and the unaudited financial report till December 1, 2024.
Besides, Navana Pharma’s credit rating has been assessed by National Credit Rating Limited. The company is rated ‘AA’ for long term and ‘ST-2’ for short term. This rating has been determined based on the audited financial report for the financial year ended on June 30, 2024.
